Cargando…
Integrated-gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) afflicts a significant percentage of the population; however, no effective treatments have yet been established because of the unsuitability of in vitro assays and animal experimental models. Here, we present an integrated-gut-liver-on-a-chip (iGLC) platform...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036655/ https://www.ncbi.nlm.nih.gov/pubmed/36959276 http://dx.doi.org/10.1038/s42003-023-04710-8 |